Lakshmi Prabhu

ORCID: 0000-0002-2093-1115

Biochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “PRMT5 is a therapeutic target in choroidal neovascularization”.

PRMT5 is a therapeutic target in choroidal neovascularization

Scientific Reports(2023)10.1038/s41598-023-28215-w

N/A

0.373DataRank · unranked

11 citations

Matthew Martin, Kamakshi Sishtla, Aishat Motolani, Mengyao Sun, Nathan R. Jensen +6 more

Regulation of a PRMT5/NF-κB Axis by Phosphorylation of PRMT5 at Serine 15 in Colorectal Cancer

International Journal of Molecular Sciences(2020)10.3390/ijms21103684

N/A

0DataRank · unranked

38 citations

Benlian Wang, Guanglong Jiang, Wei Han, Mengyao Sun, Lakshmi Prabhu +6 more

A complex signature network that controls the upregulation of PRMT5 in colorectal cancer

Genes & Diseases(2021)10.1016/j.gendis.2021.11.001

N/A

0DataRank · unranked

1 citations

Antja-Voy Hartley, Aishat Motolani, Guanglong Jiang, Ahmad R. Safa, Lakshmi Prabhu +3 more

Inhibition of PRMT5 by market drugs as a novel cancer therapeutic avenue

Genes & Diseases(2022)10.1016/j.gendis.2022.04.001

N/A

0DataRank · unranked

16 citations

Matthew Martin, Lan Chen, Özlem Demir, Jiamin Jin, Xiumei Huang +13 more

PRMT5 is a therapeutic target in choroidal neovascularization

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.03.30.486275

N/A

0DataRank · unranked

0 citations

Matthew Martin, Mengyao Sun, Kamakshi Sishtla, Nathan R. Jensen, Aishat Motolani +6 more